help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, R. W.
Right arrow Articles by DeLuca, H. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, R. W.
Right arrow Articles by DeLuca, H. F.

Journal of Clinical Endocrinology & Metabolism, Vol 46, 756-765, Copyright © 1978 by Endocrine Society


ARTICLES

Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults

RW Gray, AE Caldas, DR Wilz, J Lemann Jr, GA Smith and HF DeLuca

The synthesis of very high specific activity 25-OH-vitamin D3 (78 Ci/mmol) has made possible the study of the metabolism and plasma disappearance of 3H after a single dose of 3H-1,25-(OH)2-D3 in quantities that are only 10-20% of the endogenous plasma pool. We studied seven healthy adults who were given doses of 1,25-(OH)2-D3 ranging from 30-2300 pmol. Plasma disappearance was rapid with only 14 +/- 2% of administered 3H remaining in the plasma pool 4 h after labeling. Plasma metabolite profiles during the first 4 h showed only 1,25-(OH)2-D3. Thereafter, significant amounts of other metabolites were detected. The 6-day cumulative excretion of 3H in urine and feces (virtually all associated with metabolites of 1,25-(OH)2-D3) averaged 16 +/- 3% and 49 +/- 11% of the dose, respectively. Compartmental analysis of the isotope data for two subjects who received the smallest doses of 1,25-(OH)2-D3 indicated that endogenous renal 1,25-(OH)2-D3 synthesis rates approximate 0.8-2.4 nmol/day (0.3-1.0 microgram/day).


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
J. E Zerwekh
Blood biomarkers of vitamin D status
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1087S - 1091S.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. V. Young, G. G. Schwartz, L. Wang, D. P. Jamieson, L. W. Whitlatch, J. N. Flanagan, B. L. Lokeshwar, M. F. Holick, and T. C. Chen
The prostate 25-hydroxyvitamin D-1{alpha}-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D
Carcinogenesis, June 1, 2004; 25(6): 967 - 971.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Tryfonidou, M. A. Oosterlaken-Dijksterhuis, J. A. Mol, T. S. G. A. M. van den Ingh, W. E. van den Brom, and H. A. W. Hazewinkel
24-Hydroxylase: potential key regulator in hypervitaminosis D3 in growing dogs
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E505 - E513.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. A. Tryfonidou, J. J. Stevenhagen, G.J.C.M. van den Bemd, M. A. Oosterlaken-Dijksterhuis, H. F. DeLuca, J. A. Mol, W. E. van den Brom, J.P.T.M. van Leeuwen, and H.A.W. Hazewinkel
Moderate Cholecalciferol Supplementation Depresses Intestinal Calcium Absorption in Growing Dogs
J. Nutr., September 1, 2002; 132(9): 2644 - 2650.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. JONES, S. A. STRUGNELL, and H. F. DeLUCA
Current Understanding of the Molecular Actions of Vitamin D
Physiol Rev, October 1, 1998; 78(4): 1193 - 1231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1978 by The Endocrine Society